← Leaderboards
Michael J Mancino
Univ Of Arkansas For Med Scis
$2,277,636
Attributed
$3,711,780
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $600.1K · FY2010–19$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,711,780 · 4
By mechanism
R01$2,868,289 · 1
P20$437,866 · 2
R21$405,625 · 1
Top collaborators
- Alison Oliveto Beaudoin5 shared
Most similar at Univ Of Arkansas For Med Scis
Same institution · by research overlap
- Mark J. Edlund$2,702,772
- Teresa Jo Hudson$1,645,713
- Patricia B Wright$414,208
- Lisa Kaye Brents$416,625
Others in their field
Top investigators on “Placebos”
- Beth Baseler · Leidos Biomedical Research, Inc.$141,816,521
- Randall J Bateman · Washington University$134,290,222
- Elizabeth A Thom · George Washington University$115,751,620
- Eric Martin McDade · Washington University$96,859,497
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$93,253,804
- Georgia D Tomaras · Fred Hutchinson Cancer Center$93,253,804
Research focus
PlacebosParticipantRelapseRandomizedWithdrawalWithdrawal SymptomFda ApprovedTreatment OutcomeCravingDependencePharmaceutical PreparationsFollow-UpAgonistOutpatientsSafetyControlled Clinical TrialsClinical PracticePublic Health RelevanceProgramsPlacebo ControlHigh Risk BehaviorAddictionInterviewAdrenergic Agonists
Grant awards (9)
Improving Treatment Outcomes for Prescription Opioid Dependence$537,833
R01 · FY2019 · DA
Improving Treatment Outcomes for Prescription Opioid Dependence$578,697
R01 · FY2018 · DA
Improving Treatment Outcomes for Prescription Opioid Dependence$578,697
R01 · FY2017 · DA
Improving Treatment Outcomes for Prescription Opioid Dependence$572,912
R01 · FY2016 · DA
Improving Treatment Outcomes for Prescription Opioid Dependence$600,150
R01 · FY2015 · DA
Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence$221,250
R21 · FY2014 · DA · contact PI
Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence$184,375
R21 · FY2013 · DA · contact PI
AR CAREER DEVELOPMENT COBRE: AMPHETAMINE WITHDRAWAL PARADIGM IN HUMANS$216,712
P20 · FY2011 · RR · contact PI
AR CAREER DEVELOPMENT COBRE: AMPHETAMINE WITHDRAWAL PARADIGM IN HUMANS$221,154
P20 · FY2010 · RR · contact PI